Grady Clinical Research Center

Atlanta, Georgia 30303

0 studies enrolling now · 4 studies all time

What they study most

Chronic Limb-Threatening Ischemia, Heart Failure, Reduced Ejection Fraction

Studies at this site

• Esprit BTK Post-Approval Study — Running, not enrolling
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction — Status unconfirmed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed